Cardiovascular Systems, Inc. CSII recently announced an acquisition option agreement with Chansu Vascular Technologies, LLC (CVT) for the development of a peripheral everolimus drug-coated balloon ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Historically, much of the research conducted in our 'Heart Lab' has been at the interface of medicine and engineering, dedicated to the discovery and development of innovative methodologies (molecular ...

Cellular biomechanics of neural and vascular injury, mechanotransduction in the cardiovascular system, mechanical control of growth and development for wound healing and tissue engineering Engineering ...

The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution. Microphysical systems (MPSs) ...

Exposure to high levels of the body's primary stress hormone—cortisol—in preterm fetuses can disrupt normal heart development, potentially increasing the risk of cardiovascular disease in later life.

UCLA researchers have successfully grown miniature lungs from stem cells—complete with their own functioning blood vessel networks. Subscribe to our newsletter for the latest sci-tech news updates.

Coronary arteries are a vital part of the human heart, providing it with oxygen-rich blood so that it can work. By comparing the hearts of mammals, birds, reptiles, fish and frogs, a ...

The field of tumor microenvironment research has increasingly highlighted the intertwined relationship between aberrant vasculature and dysregulated immune ...

According to the State of Cardiovascular Health in the European Union (EU) report, published on Dec 15, 2025, by the Organisation for Economic Co-operation and Development (OECD), cardiovascular ...